189 related articles for article (PubMed ID: 20100777)
21. The Role of Beta-Blockers in the Treatment of Hypertension.
Cruickshank JM
Adv Exp Med Biol; 2017; 956():149-166. PubMed ID: 27957711
[TBL] [Abstract][Full Text] [Related]
22. Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis.
Psaty BM; Lumley T; Furberg CD; Schellenbaum G; Pahor M; Alderman MH; Weiss NS
JAMA; 2003 May; 289(19):2534-44. PubMed ID: 12759325
[TBL] [Abstract][Full Text] [Related]
23. The association of antihypertensive agents with MRI white matter findings and with Modified Mini-Mental State Examination in older adults.
Heckbert SR; Longstreth WT; Psaty BM; Murros KE; Smith NL; Newman AB; Williamson JD; Bernick C; Furberg CD
J Am Geriatr Soc; 1997 Dec; 45(12):1423-33. PubMed ID: 9400550
[TBL] [Abstract][Full Text] [Related]
24. Calcium channel blockers versus other classes of drugs for hypertension.
Zhu J; Chen N; Zhou M; Guo J; Zhu C; Zhou J; Ma M; He L
Cochrane Database Syst Rev; 2022 Jan; 1(1):CD003654. PubMed ID: 35000192
[TBL] [Abstract][Full Text] [Related]
25. Calcium channel blockers versus other classes of drugs for hypertension.
Zhu J; Chen N; Zhou M; Guo J; Zhu C; Zhou J; Ma M; He L
Cochrane Database Syst Rev; 2021 Oct; 10(10):CD003654. PubMed ID: 34657281
[TBL] [Abstract][Full Text] [Related]
26. The case for beta-blockers as first-line antihypertensive therapy.
Cruickshank JM
J Hypertens Suppl; 1992 Jun; 10(3):S21-7. PubMed ID: 1353111
[TBL] [Abstract][Full Text] [Related]
27. Reexamining the Effect of Antihypertensive Medications on Falls in Old Age.
Lipsitz LA; Habtemariam D; Gagnon M; Iloputaife I; Sorond F; Tchalla AE; Dantoine TF; Travison TG
Hypertension; 2015 Jul; 66(1):183-9. PubMed ID: 25941341
[TBL] [Abstract][Full Text] [Related]
28. Diuretic or Beta-Blocker for Hypertensive Patients Already Receiving ACEI/ARB and Calcium Channel Blocker.
Tsai MS; Tang CH; Lin CY; Chuang PY; Chen NC; Huang CH; Chang WT; Wang TD; Yu PH; Chen WJ
Cardiovasc Drugs Ther; 2017 Dec; 31(5-6):535-543. PubMed ID: 29218625
[TBL] [Abstract][Full Text] [Related]
29. Cardiovascular events in elderly patients with isolated systolic hypertension. A subgroup analysis of treatment strategies in STOP-Hypertension-2.
Ekbom T; Linjer E; Hedner T; Lanke J; De Faire U; Wester PO; Dahlöf B; Scherstén B
Blood Press; 2004; 13(3):137-41. PubMed ID: 15223721
[TBL] [Abstract][Full Text] [Related]
30. Randomised trial of effects of calcium antagonists compared with diuretics and beta-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study.
Hansson L; Hedner T; Lund-Johansen P; Kjeldsen SE; Lindholm LH; Syvertsen JO; Lanke J; de Faire U; Dahlöf B; Karlberg BE
Lancet; 2000 Jul; 356(9227):359-65. PubMed ID: 10972367
[TBL] [Abstract][Full Text] [Related]
31. Outcomes with Angiotensin-converting Enzyme Inhibitors vs Other Antihypertensive Agents in Hypertensive Blacks.
Bangalore S; Ogedegbe G; Gyamfi J; Guo Y; Roy J; Goldfeld K; Torgersen C; Capponi L; Phillips C; Shah NR
Am J Med; 2015 Nov; 128(11):1195-203. PubMed ID: 26071821
[TBL] [Abstract][Full Text] [Related]
32. First-line drugs for hypertension.
Wright JM; Musini VM; Gill R
Cochrane Database Syst Rev; 2018 Apr; 4(4):CD001841. PubMed ID: 29667175
[TBL] [Abstract][Full Text] [Related]
33. Effects of Long- and Intermediate-Acting Dihydropyridine Calcium Channel Blockers in Hypertension: A Systematic Review and Meta-Analysis of 18 Prospective, Randomized, Actively Controlled Trials.
Chaugai S; Sherpa LY; Sepehry AA; Kerman SRJ; Arima H
J Cardiovasc Pharmacol Ther; 2018 Sep; 23(5):433-445. PubMed ID: 29739234
[TBL] [Abstract][Full Text] [Related]
34. Long-term effects of antihypertensive drugs on the risk of new-onset diabetes in elderly Taiwanese hypertensives.
Liou YS; Ma T; Tien L; Chien C; Chou P; Jong GP
Int Heart J; 2008 Mar; 49(2):205-11. PubMed ID: 18475020
[TBL] [Abstract][Full Text] [Related]
35. Description of antihypertensive use in patients with resistant hypertension prescribed four or more agents.
Hanselin MR; Saseen JJ; Allen RR; Marrs JC; Nair KV
Hypertension; 2011 Dec; 58(6):1008-13. PubMed ID: 22042809
[TBL] [Abstract][Full Text] [Related]
36. Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial.
Black HR; Elliott WJ; Grandits G; Grambsch P; Lucente T; White WB; Neaton JD; Grimm RH; Hansson L; Lacourciere Y; Muller J; Sleight P; Weber MA; Williams G; Wittes J; Zanchetti A; Anders RJ;
JAMA; 2003 Apr 23-30; 289(16):2073-82. PubMed ID: 12709465
[TBL] [Abstract][Full Text] [Related]
37. Nebivolol for the Treatment of Essential Systemic Arterial Hypertension: A Systematic Review and Meta-Analysis.
Seleme VB; Marques GL; Mendes AEM; Rotta I; Pereira M; Júnior EL; da Cunha CLP
Am J Cardiovasc Drugs; 2021 Mar; 21(2):165-180. PubMed ID: 32710438
[TBL] [Abstract][Full Text] [Related]
38. [Interactions between antihypertensive drugs].
Takagi M; Matsuoka H
Nihon Rinsho; 1992 May; 50 Suppl():23-27. PubMed ID: 1355126
[No Abstract] [Full Text] [Related]
39. [Pharmacological basis of antihypertensive drug therapy].
Kolck UW; Zaugg CE; Erne P
Praxis (Bern 1994); 2004 May; 93(20):847-56. PubMed ID: 15195836
[TBL] [Abstract][Full Text] [Related]
40. [Recent intervention studies with antihypertensive drugs and their influence on guidelines].
Rahn KH
Med Klin (Munich); 2003 Dec; 98(12):771-5. PubMed ID: 14685679
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
